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High Variability in Outcomes of Two-Stage Exchange to
Treat Periprosthetic Joint Infection
Benjamin Zmistowski BS, Paul M. Lichstein MD, Aaron Carter MD, Joshua J. Minori DO, Javad Parvizi MD, FRCS.
Investigation performed at the Rothman Institute of Orthopaedics at the Thomas Jefferson University Hospital, Philadelphia, PA

INTRODUCTION
Periprosthetic joint infection (PJI) is a challenging condition to
manage with sobering morbidity and mortality.1,2 Treatment options
range from simple irrigation and debridement with prosthetic retention
to explantation and placement of a temporary cement spacer.
Indictations for each option are unclear and non-uniform despite
significant efforts to understand the management outcomes. Until
recently, a uniform definition of success was unavailable, thus clouding
the discussion of treatment options. Two-stage exchange is currently
considered the “gold-standard” in North America, yet an appropriate
understanding of the actual success and ancillary effects of treatment is
needed. With the advantage of an expert opinion defining success, this
study was designed to understand the status of the current literature and
the guidance it provides regarding two-stage exchange arthroplasty.

The Delphi Method for PJI – Success Defined
- Infection eradication - characterized by a healed wound
without fistula, drainage, or pain, and no infection
recurrence caused by the same organism strain.
- No subsequent surgical intervention for (sepsis, necrotizing
fasciitis).
- No occurrence of PJI-related mortality (by causes such as
sepsis, necrotizing fasciitis).
- Retention of prosthesis is not the only defining factor of
success.

TABLE 1
Number of Articles Assessed
Date Published (Range)

MATERIALS AND METHODS
All pertinent publications regarding outcomes of two-stage
exchange involving more than 10 hip arthroplasties, from 1991 to 2012,
were assembled and reviewed. Rates of infection eradication,
non-infectious complications and demographic details were collected.
Fifty-one published articles that included a total of 2,444 infected total
hip arthroplasties treated with a two-stage protocol were included
(Table 1). In addition to ascertaining the reported success rate, each
article was reviewed for reporting of the components constituting
successful PJI treatment as described by Diaz-Ledezma et al.3 These
components include: (1) infection eradication, (2) no subsequent
surgical intervention, and (3) no occurrence of PJI-related mortality.

51
1991-2012

RESULTS
The reported success rate in these studies for two-stage exchange
arthroplasty ranged from 78% to 100% (Standard Deviation = 6.09%).
Statistically significant correlation between reported outcome and sample
size, year of publication, average age, gender, inter-stage duration, number
of methicillin-resistant Staphylococcus aureus infections, and length of follow
up were not appreciated.
Measures of a successful PJI treatment were not easily extracted from this
literature. Forty (78%), 16 (31%), 0 (0%), and 32 (63%) cases provided
inadequate data to determine clinical failure, infection recurrence with
identical organism, reoperation secondary to infection, or infection-related
mortality, respectively. Only 4 cases (8%) provided sufficient information to
assess the success of treatment with definition provided by Diaz-Ledezma et
al.

Average (Range)

DISCUSSION

Reported Number of Patients per Article

46 (8-202)

Age (Years)

63 (49-72)

Males

26 (4-109)

Females

22 (2-95)

Number of Patients that Received Reimplantation

45 (8-186)

Despite advances in the diagnosis and management of PJI, the outcome
of the most commonly implemented surgical protocol for treatment remains
highly variable and generally unpredictable. As such, perhaps evidence is
insufficient to suggest this modality is appropriately labeled as a
“gold-standard.” Given the severe impact of PJI on the mortality and
morbidity of arthroplasty patients, future endeavors involving well
controlled and defined investigations are imperative.

Compiled data

Average Follow-Up (Months)

57 (20.4-168)

Minimum Follow-Up (Months)

26 (2-120)

Maximum Follow-Up (Months)

102 (36-203.5)

Table 1.

Compilation of data from the 51 articles assesed in this analysis.
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